TY - JOUR
T1 - Repurposing of a nucleoside scaffold from adenosine receptor agonists to opioid receptor antagonists
AU - Tosh, Dilip K.
AU - Ciancetta, Antonella
AU - Mannes, Philip
AU - Warnick, Eugene
AU - Janowsky, Aaron
AU - Eshleman, Amy J.
AU - Gizewski, Elizabeth
AU - Brust, Tarsis F.
AU - Bohn, Laura M.
AU - Auchampach, John A.
AU - Gao, Zhan Guo
AU - Jacobson, Kenneth A.
N1 - Funding Information:
We acknowledge the support from the NIH Intramural Research Program (NIDDK, ZIA DK031117-28). We thank John Lloyd (NIDDK) for mass spectral determinations and Robert O’Connor (NIDDK) for NMR spectra. We thank Dr. Bryan L. Roth (University of North Carolina at Chapel Hill) and National Institute of Mental Health’s Psychoactive Drug Screening Program (contract # HHSN-271-2008-00025-C) for screening data. We also thank the NIH National Institute on Drug Abuse (NIDA)/VA Interagency Agreement #ADA12013; the Methamphetamine Abuse Research Center (P50 DA018165-06), and the Department of Veterans Affairs Research Career Scientist and Merit Review Programs, and NIDA (R01DA031297) to L.M.B.
Publisher Copyright:
© 2018 American Chemical Society.
PY - 2018/10/31
Y1 - 2018/10/31
N2 - While screening off-target effects of rigid (N)methanocarba-adenosine 5′-methylamides as A3 adenosine receptor (AR) agonists, we discovered μM binding hits at the δ-opioid receptor (DOR) and translocator protein (TSPO). In an effort to increase OR and decrease AR affinity by structure activity analysis of this series, antagonist activity at κ-(K)OR appeared in 5′-esters (ethyl 24 and propyl 30), which retained TSPO interaction (μM). 7-Deaza modification of C2-(arylethynyl)-5′-esters but not 4′-truncation enhanced KOR affinity (MRS7299 28 and 29, Ki ≈ 40 nM), revealed μOR and DOR binding, and reduced AR affinity. Molecular docking and dynamics simulations located a putative KOR binding mode consistent with the observed affinities, placing C7 in a hydrophobic region. 3-Deaza modification permitted TSPO but not OR binding, and 1-deaza was permissive to both; ribose-restored analogues were inactive at both. Thus, we have repurposed a known AR nucleoside scaffold for OR antagonism, with a detailed hypothesis for KOR recognition.
AB - While screening off-target effects of rigid (N)methanocarba-adenosine 5′-methylamides as A3 adenosine receptor (AR) agonists, we discovered μM binding hits at the δ-opioid receptor (DOR) and translocator protein (TSPO). In an effort to increase OR and decrease AR affinity by structure activity analysis of this series, antagonist activity at κ-(K)OR appeared in 5′-esters (ethyl 24 and propyl 30), which retained TSPO interaction (μM). 7-Deaza modification of C2-(arylethynyl)-5′-esters but not 4′-truncation enhanced KOR affinity (MRS7299 28 and 29, Ki ≈ 40 nM), revealed μOR and DOR binding, and reduced AR affinity. Molecular docking and dynamics simulations located a putative KOR binding mode consistent with the observed affinities, placing C7 in a hydrophobic region. 3-Deaza modification permitted TSPO but not OR binding, and 1-deaza was permissive to both; ribose-restored analogues were inactive at both. Thus, we have repurposed a known AR nucleoside scaffold for OR antagonism, with a detailed hypothesis for KOR recognition.
UR - http://www.scopus.com/inward/record.url?scp=85054509636&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054509636&partnerID=8YFLogxK
U2 - 10.1021/acsomega.8b01237
DO - 10.1021/acsomega.8b01237
M3 - Article
AN - SCOPUS:85054509636
SN - 2470-1343
VL - 3
SP - 12658
EP - 12678
JO - ACS Omega
JF - ACS Omega
IS - 10
ER -